Science Explorer Back to mapMap
Discussion
Researcher · Bluebird Bio (United States) · United States

Kevin M. Friedman

Kevin M. Friedman publishes mostly in Oncology, Immunology and Molecular Biology, on topics such as CAR-T cell therapy research, Immune Cell Function and Interaction and Immunotherapy and Immune Responses.

OpenAlex
World rank
#2,305,880
of 7,710,434 ranked researchers
Rank in United States
#687,604
of 1,627,098
Works
24
Citations
2.6k
Citations per work
108.0
h-index
11
i10-index 11Top 54% in Oncology
Kevin M. Friedman

What does Kevin M. Friedman research?

Kevin M. Friedman's work is mostly in Medicine (46%), Immunology and Microbiology (31%), Biochemistry, Genetics and Molecular Biology (15%).

Health Sciences: 11 works · 46.3% of their workMedicine: 11 works · 46.3% of their workOncology: 9 works · 37.3% of their workRadiology, Nuclear Medicine and Imaging: 1 works · 6.0% of their workHematology: 1 works · 3.0% of their workLife Sciences: 11 works · 46.2% of their workImmunology and Microbiology: 8 works · 31.3% of their workImmunology: 8 works · 31.3% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 14.9% of their workMolecular Biology: 4 works · 14.9% of their workEverything else: 1 works · 4.5% of their workPhysical Sciences: 1 works · 3.0% of their workEngineering: 1 works · 3.0% of their workBiomedical Engineering: 1 works · 3.0% of their workTHEIR WORKKevin M. Friedman24works
Life Sciences46%Physical Sciences3%Health Sciences46%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1146.3%
    1. Immunology and Microbiology831.3%
    2. Biochemistry, Genetics and Molecular Biology414.9%
  3. Everything else14.5%
    1. Engineering13.0%
  1. 1Oncology37% of their works
  2. 2Immunology31% of their works
  3. 3Molecular Biology15% of their works
  4. 4Radiology, Nuclear Medicine and Imaging6% of their works
  5. 5Biomedical Engineering3% of their works
  6. 6Hematology3% of their works

Research topics

Which keywords describe Kevin M. Friedman's research?

The keywords of their largest research topics: Cancer Immunotherapy, CAR T Cells, Chimeric Antigen Receptor, Natural Killer Cells, NK Cell Recognition, Glycosylation, Dendritic Cells and Immunity.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Cancer Immunotherapy252 topics
  2. CAR T Cells191 topic
  3. Chimeric Antigen Receptor191 topic
  4. NK Cell Recognition81 topic
  5. Natural Killer Cells81 topic
  6. Glycosylation72 topics
  7. Dendritic Cells61 topic
  8. Immunity61 topic
  9. Monoclonal Antibodies62 topics
  10. Fc Receptors41 topic
  11. Foxp341 topic
  12. TGF-ß41 topic
  13. Therapeutic Antibodies41 topic
  14. Mammalian Cells31 topic
  15. Recombinant Protein31 topic
  16. Biosimilars21 topic
  17. Diagnosis Criteria21 topic
  18. Immunogenicity21 topic
  19. International Myeloma Working Group21 topic

Where does Kevin M. Friedman work?

Kevin M. Friedman's main affiliation in the publication record is Bluebird Bio (United States), United States.

How many publications and citations does Kevin M. Friedman have?

OpenAlex counts 24 works and 2,591 citations for Kevin M. Friedman, an h-index of 11, ranking #2,305,880 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Kevin M. Friedman. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.